OXFORD IMMUNOTEC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA
NEW ORLEANS, Feb. 9, 2021 OXFORD IMMUNOTEC Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Oxford Immunotec Global PLC (NasdaqGS: OXFD) to PerkinElmer, Inc. (NYSE: PKI). Under the terms of the proposed transaction, shareholders of Oxford will receive only $22.00 in cash for each share of Oxford that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/ or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-oxfd/ to learn more.
Oxford Immunotec is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease. The Company’s T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA. http://www.oxfordimmunotec.com/north-america/wp-content/uploads/sites/2/Disclaimer-V2.pdf
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
Kahn Swick & Foti, LLC
1100 Poydras St., Suite 3200
New Orleans, LA 70163
This news is conveyed to prattle prattle news through a press release
By PR Newswire